Yuan, Gang
Flores, Natasha M.
Hausmann, Simone
Lofgren, Shane M.
Kharchenko, Vladlena
Angulo-Ibanez, Maria
Sengupta, Deepanwita
Lu, Xiaoyin
Czaban, Iwona http://orcid.org/0000-0002-8038-1573
Azhibek, Dulat
Vicent, Silvestre
Fischle, Wolfgang
Jaremko, Mariusz
Fang, Bingliang
Wistuba, Ignacio I.
Chua, Katrin F. http://orcid.org/0000-0003-3821-4226
Roth, Jack A. http://orcid.org/0000-0002-8955-1313
Minna, John D.
Shao, Ning-Yi http://orcid.org/0000-0003-4231-828X
Jaremko, Ćukasz http://orcid.org/0000-0001-7684-9359
Mazur, Pawel K. http://orcid.org/0000-0002-5820-8344
Gozani, Or http://orcid.org/0000-0002-1365-4463
Article History
Received: 30 April 2020
Accepted: 23 December 2020
First Online: 3 February 2021
Competing interests
: O.G. is a co-founder of EpiCypher, Inc. and Athelas Therapeutics, Inc. J.A.R. is a consultant and stock owner (including pending patents) in Genprex, Inc. P.K.M. is a co-founder of Amplified Medicines, Inc. The other authors declare no competing interests.